A Transparency Market Research report forecasts that the worldwide market for drug-device combination products such as drug-eluting stents, bone grafts and infusion pumps will increase from $66 billion in 2012 to $115.1 billion by 2019. Growth will be driven in part by the rising number of chronic obstructive pulmonary disease, asthma and cardiovascular disease cases, the report notes.
Report: Drug-device combo market is poised for robust growth
SmartBrief Job Listings for Health Care
|Senior Director, Biostatistics||
|Associate - Food and Drug||
Keller and Heckman LLP
|Senior Paralegal - Research & Development, and Medical||